These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6791198)

  • 1. Threshold differences for naloxone and naltrexone in the hypothalamus and midbrain using fixed ratio brain self-stimulation in rats.
    Schaefer GJ; Michael RP
    Psychopharmacology (Berl); 1981; 74(1):17-22. PubMed ID: 6791198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphine withdrawal produces differential effects on the rate of lever-pressing for brain self-stimulation in the hypothalamus and midbrain in rats.
    Schaefer GJ; Michael RP
    Pharmacol Biochem Behav; 1983 Apr; 18(4):571-7. PubMed ID: 6683408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of opioid antagonists and their quaternary derivatives on locomotor activity and fixed ratio responding for brain self-stimulation in rats.
    Schaefer GJ; Michael RP
    Pharmacol Biochem Behav; 1985 Nov; 23(5):797-802. PubMed ID: 4080766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of naloxone with morphine, amphetamine and phencyclidine on fixed interval responding for intracranial self-stimulation in rats.
    Schaefer GJ; Michael RP
    Psychopharmacology (Berl); 1990; 102(2):263-8. PubMed ID: 2274609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing the work requirements lowers the threshold of naloxone for reducing self-stimulation in the midbrain of rats.
    West CH; Schaefer GJ; Michael RP
    Pharmacol Biochem Behav; 1983 May; 18(5):705-10. PubMed ID: 6856645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-administration of D-Ala2-Met-enkephalinamide at hypothalamic self-stimulation sites.
    Olds ME; Williams KN
    Brain Res; 1980 Jul; 194(1):155-70. PubMed ID: 7378834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naloxone and diprenorphine reduce responding for brain self-stimulation in a fixed-ratio schedule in rats.
    Schaefer GJ; Michael RP
    Pharmacol Biochem Behav; 1988 Jan; 29(1):209-12. PubMed ID: 3353428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the effects of morphine, pentazocine, cyclazocine and amphetamine on intracranial self-stimulation in the rat.
    Holtzman SG
    Psychopharmacologia; 1976 Apr; 46(3):223-7. PubMed ID: 951457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic effects of naltrexone and naloxone on schedule-controlled behavior of squirrel monkeys and pigeons.
    Goldberg SR; Morse WH; Goldberg DM
    J Pharmacol Exp Ther; 1981 Mar; 216(3):500-9. PubMed ID: 7205630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response functions of apomorphine, SKF 38393, LY 171555, haloperidol and clonidine on the self-stimulation evoked from lateral hypothalamus and ventral tegmentum.
    Singh J; Desiraju T; Raju TR
    Indian J Physiol Pharmacol; 1996 Jan; 40(1):15-22. PubMed ID: 8864766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naltrexone maintenance fails to alter amphetamine effects on intracranial self-stimulation in rats.
    Sakloth F; Negus SS
    Exp Clin Psychopharmacol; 2018 Apr; 26(2):195-204. PubMed ID: 29528663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of morphine and naloxone on thresholds of ventral tegmental electrical self-stimulation.
    van Wolfswinkel L; van Ree JM
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):84-92. PubMed ID: 4047179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naloxone pretreatment blocks acute morphine-induced sensitization to naltrexone.
    White-Gbadebo D; Holtzman S
    Psychopharmacology (Berl); 1994 Mar; 114(2):225-8. PubMed ID: 7838911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain site variations in effects of morphine on electrical self-stimulation.
    Nelson WT; Steiner SS; Brutus M; Farrell R; Ellman SJ
    Psychopharmacology (Berl); 1981; 74(1):58-65. PubMed ID: 6791206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In rats, acute morphine dependence results in antagonist-induced response suppression of intracranial self-stimulation.
    Easterling KW; Holtzman SG
    Psychopharmacology (Berl); 2004 Sep; 175(3):287-95. PubMed ID: 15024547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
    Liu J; Schulteis G
    Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of the discriminative effects of morphine in the rat by naltrexone and naloxone.
    Shannon HE; Holtzman SG
    Psychopharmacology (Berl); 1976 Nov; 50(2):119-24. PubMed ID: 826950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addictive agents and intracranial stimulation (ICS): novel antagonists and agonists of morphine and pressing for ICS.
    Bermudez-Rattoni F; Cruz-Morales S; Reid LD
    Pharmacol Biochem Behav; 1983 May; 18(5):777-84. PubMed ID: 6856650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitation of self-stimulation of ventral tegmentum by microinjection of opioid receptor subtype agonists.
    Singh J; Desiraju T; Nagaraja TN; Raju TR
    Physiol Behav; 1994 Apr; 55(4):627-31. PubMed ID: 7910690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-specific naloxone blockade of brain self-stimulation duration.
    Freedman NL; Pangborn D
    Pharmacol Biochem Behav; 1984 Mar; 20(3):361-6. PubMed ID: 6608735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.